“…In spite of these receptors' biological and clinical importance, studies on their evolution are limited and have predomi-nantly focused on individual receptor subtypes, namely TAAR (Gloriam et al, 2005;Lindemann et al, 2005;Hashiguchi and Nishida, 2007), DRD (Callier et al, 2003;Yamamoto et al, 2013), and 5HTR (Anbazhagan et al, 2010). Moreover, many of these studies, and indeed studies on the general evolution of the Rhodopsin-like family, have examined very narrow species distributions, for instance specifically teleosts (Gloriam et al, 2005), primates (Anbazhagan et al, 2010), humans and mice (Vassilatis et al, 2003;Kakarala and Jamil, 2014), or even strictly humans (Fredriksson et al, 2003).…”